In pancreatic cancer, ABCG2 [34], ABCC1, ABCC5 [35], and ABCA8 [36] have been specifically reported to be associated with gemcitabine resistance, whereas additional ABC transporters are widely expressed in chemoresistant PDAC cells [37]. This evidence concerns the gene ABCG2 and familial pancreatic carcinoma.